Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$25.63 USD
+0.37 (1.46%)
Updated May 10, 2024 04:00 PM ET
After-Market: $25.58 -0.05 (-0.20%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | -63.16% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.08 |
Next Year | 0.32 |
EPS (TTM) | -5.25 |
P/E (F1) | 320.38 |
% EPS Growth Estimates | ANIK | IND | S&P |
---|---|---|---|
Current Qtr (06/2024) | 94.74 | 5,941.58 | 8.49 |
Next Qtr (09/2024) | 120.00 | 161.80 | 11.23 |
Current Year (12/2024) | 101.42 | 12.90 | 15.67 |
Next Year (12/2025) | 300.00 | 8.50 | 9.31 |
Past 5 Years | -168.60 | 1.00 | 8.10 |
Next 5 Years | 10.00 | 20.10 | NA |
PE | 320.38 | -3.80 | 21.14 |
PEG Ratio | 32.04 | -0.19 | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 39.90M | 43.66M | 170.02M | 179.37M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 39.90M | 43.66M | 170.02M | 179.37M |
Low Estimate | 39.90M | 43.66M | 170.02M | 179.37M |
Year ago Sales | 44.30M | 41.47M | 166.66M | 170.02M |
Year over Year Growth Est. | -9.94% | 5.28% | 2.01% | 5.50% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | 0.09 | 0.08 | 0.32 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | 0.00 | 0.00 | -0.20 | -0.01 |
High Estimate | -0.01 | 0.09 | 0.21 | 0.33 |
Low Estimate | -0.01 | 0.09 | -0.05 | 0.31 |
Year ago EPS | -0.19 | -0.45 | -5.64 | 0.08 |
Year over Year Growth Est. | 94.74% | 120.00% | 101.42% | 300.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 1 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 0 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | 0.09 | 0.08 | 0.32 |
7 Days Ago | 0.00 | 0.00 | 0.01 | 0.16 |
30 Days Ago | 0.00 | 0.00 | 0.01 | 0.16 |
60 Days Ago | -0.10 | -0.14 | -0.40 | NA |
90 Days Ago | -0.10 | -0.14 | -0.40 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.01 | 0.09 | -0.05 | 0.31 |
Zacks Consensus Estimate | -0.01 | 0.09 | 0.08 | 0.32 |
Earnings ESP | 0.00% | 0.00% | -162.50% | -3.13% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -4.30 | -0.45 | -0.19 | NA |
Estimate | -0.19 | -0.26 | -0.33 | -0.34 | NA |
Difference | -0.12 | -4.04 | -0.12 | 0.15 | -1.03 |
Surprise | -63.16% | -1,553.85% | -36.36% | 44.12% | -402.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more